EXtension of Tablo TrEatmeNt Duration Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

33 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-25

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy \> 12 hours.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study

NCT04912024

End Stage Kidney Disease End Stage Renal Disease Acute Kidney Injury

COMPLETED

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

NCT04985383

End-Stage Renal Disease

COMPLETED NA

The EvAluation of TaBlo In-CLinic and In-HOme

NCT02460263

End Stage Renal Disease

COMPLETED NA

Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease

NCT01721421

End Stage Renal Disease

UNKNOWN NA

Mechanisms and Treatment of Intradialytic Hypertension - Sodium

NCT01371890

Hemodialysis End-stage Renal Disease Hypertension +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Disease (ESRD) End Stage Renal Disease on Dialysis Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tablo Hemodialysis System

Hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy \> 12 hours on the Tablo Hemodialysis System

Tablo Hemodialysis System

Intervention Type DEVICE

Renal Replacement Therapy between 12\< to ≤ 24 hours.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tablo Hemodialysis System

Renal Replacement Therapy between 12\< to ≤ 24 hours.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant weighs ≥ 34kg.
* Participant is hospitalized and has dialysis dependent End-Stage Kidney Disease or Acute Kidney Injury and is prescribed renal replacement therapy \> 12 hours.